Michael Lee

Array ( [id] => 3812522 [patent_doc_number] => 05789229 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Stranded RNA virus particles' [patent_app_type] => 1 [patent_app_number] => 8/514975 [patent_app_country] => US [patent_app_date] => 1995-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13821 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789229.pdf [firstpage_image] =>[orig_patent_app_number] => 514975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190330 [patent_doc_number] => 06043081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Expression vectors encoding recombinant proteins comprising a VPR/VPX virion incorporation domain for targeting into HIV-1 or HIV-2 virions' [patent_app_type] => 1 [patent_app_number] => 8/524694 [patent_app_country] => US [patent_app_date] => 1995-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 13 [patent_no_of_words] => 10865 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043081.pdf [firstpage_image] =>[orig_patent_app_number] => 524694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3985027 [patent_doc_number] => 05861478 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Lytic peptides' [patent_app_type] => 1 [patent_app_number] => 8/301736 [patent_app_country] => US [patent_app_date] => 1995-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 31 [patent_no_of_words] => 9333 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861478.pdf [firstpage_image] =>[orig_patent_app_number] => 301736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4130121 [patent_doc_number] => 06146886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'RNA polymerase III-based expression of therapeutic RNAs' [patent_app_type] => 1 [patent_app_number] => 8/512861 [patent_app_country] => US [patent_app_date] => 1995-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 37 [patent_no_of_words] => 10310 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146886.pdf [firstpage_image] =>[orig_patent_app_number] => 512861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4233069 [patent_doc_number] => 06074865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Recombinant dengue virus DNA fragment' [patent_app_type] => 1 [patent_app_number] => 8/504878 [patent_app_country] => US [patent_app_date] => 1995-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9169 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/074/06074865.pdf [firstpage_image] =>[orig_patent_app_number] => 504878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3687018 [patent_doc_number] => 05691198 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'p16 expression constructs and their application in cancer therapy' [patent_app_type] => 1 [patent_app_number] => 8/502881 [patent_app_country] => US [patent_app_date] => 1995-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 18994 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691198.pdf [firstpage_image] =>[orig_patent_app_number] => 502881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284449 [patent_doc_number] => 06210919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Genetic sequences and proteins related to alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/496841 [patent_app_country] => US [patent_app_date] => 1995-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 20755 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/210/06210919.pdf [firstpage_image] =>[orig_patent_app_number] => 496841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4146149 [patent_doc_number] => 06031150 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Sulfonylurea receptor trangenic rodents' [patent_app_type] => 1 [patent_app_number] => 8/476900 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 41270 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/031/06031150.pdf [firstpage_image] =>[orig_patent_app_number] => 476900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4084093 [patent_doc_number] => 06054566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Recombinant animal viral nucleic acids' [patent_app_type] => 1 [patent_app_number] => 8/484341 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 35189 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054566.pdf [firstpage_image] =>[orig_patent_app_number] => 484341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4125906 [patent_doc_number] => 06120764 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Adenoviruses for control of gene expression' [patent_app_type] => 1 [patent_app_number] => 8/486549 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 9875 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/120/06120764.pdf [firstpage_image] =>[orig_patent_app_number] => 486549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4067377 [patent_doc_number] => 05866755 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Animals transgenic for a tetracycline-regulated transcriptional inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/486814 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 37892 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866755.pdf [firstpage_image] =>[orig_patent_app_number] => 486814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995604 [patent_doc_number] => 05985846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Gene therapy for muscular dystrophy' [patent_app_type] => 1 [patent_app_number] => 8/488014 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 15564 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985846.pdf [firstpage_image] =>[orig_patent_app_number] => 488014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915531 [patent_doc_number] => 06001990 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Antisense inhibition of hepatitis C virus' [patent_app_type] => 1 [patent_app_number] => 8/474700 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 12120 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001990.pdf [firstpage_image] =>[orig_patent_app_number] => 474700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4106547 [patent_doc_number] => 06100443 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Universal donor cells' [patent_app_type] => 1 [patent_app_number] => 8/483433 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 20565 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100443.pdf [firstpage_image] =>[orig_patent_app_number] => 483433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3887505 [patent_doc_number] => 05834248 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Compositions and methods using rchd534, a gene uregulated by shear stress' [patent_app_type] => 1 [patent_app_number] => 8/480994 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 43465 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834248.pdf [firstpage_image] =>[orig_patent_app_number] => 480994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3801046 [patent_doc_number] => 05853765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Anti-cholesterolemic egg, vaccine and method for production, and use' [patent_app_type] => 1 [patent_app_number] => 8/487419 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13151 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/853/05853765.pdf [firstpage_image] =>[orig_patent_app_number] => 487419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4065998 [patent_doc_number] => 05895833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-20 [patent_title] => 'Production of human recombinant collagen in the milk of transgenic animals' [patent_app_type] => 1 [patent_app_number] => 8/485194 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5518 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/895/05895833.pdf [firstpage_image] =>[orig_patent_app_number] => 485194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013305 [patent_doc_number] => 05962648 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Production of human recombinant collagen in the milk of transgenic mammals' [patent_app_type] => 1 [patent_app_number] => 8/473465 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5522 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962648.pdf [firstpage_image] =>[orig_patent_app_number] => 473465 [rel_patent_id] =>[rel_patent_doc_number] =>)